The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy.

Voigt T, Neve A, Schümperli D. Neuropathol Appl Neurobiol. 2014 Jun;40(4):416-34

19 September 2014

A PiggyBac-mediated approach for muscle gene transfer or cell therapy.

Ley D, Van Zwieten R, Puttini S, Iyer P, Cochard A, Mermod N. Stem Cell Res. 2014 Sep 8;13(3PA):390-403.

08 September 2014

The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet.

Pérez-Schindler J, Svensson K, Vargas-Fernández E, Santos G, Wahli W, Handschin C. Diabetologia. 2014 Aug 13.

25 August 2014

Santhera Repositions Omigapil in Congenital Muscular Dystrophy and Initiates Clinical Development Program with Public-Private Partners

17 Juli 2014

Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy.

van Zwieten RW, Puttini S, Lekka M, Witz G, Gicquel-Zouida E, Richard I, Lobrinus JA, Chevalley F, Brune H, Dietler G, Kulik A, Kuntzer T, Mermod N. Nanomedicine...

12 Juni 2014

Chloride channels in myotonia congenita assessed by velocity recovery cycles.

Tan SV, Z'Graggen WJ, Boërio D, Rayan DR, Norwood F, Ruddy D, Howard R, Hanna MG, Bostock H. Muscle Nerve. 2014 Jun;49(6):845-57.

11 Juni 2014

Transcriptional network analysis in muscle reveals AP-1 as a partner of PGC-1α in the regulation of the hypoxic gene program.

Baresic M, Salatino S, Kupr B, van Nimwegen E, Handschin C. Mol Cell Biol. 2014 Jun 9.

09 Juni 2014

Santhera Reports Positive Outcome for Catena®/Raxone® in Phase III DMD Trial Supported by Additional Respiratory Function Data

23 Mai 2014

Santhera Announces Successful Outcome of Phase III Study with Catena/Raxone (INN: Idebenone) in Duchenne Muscular Dystrophy

13 Mai 2014

The craniosacral progression of muscle development influences the emergence of neuromuscular junction alterations in a severe murine model for spinal muscular atrophy.

Voigt T, Neve A, Schümperli D. Neuropathol Appl Neurobiol. 2014 Jun;40(4):416-34.

08 Mai 2014